Emcyte PureBMC® Bone Marrow Concentrate (BMC) Kit
PureBMC® – Advancing Bone Marrow Concentrate Therapy
As a physician, you strive to provide the most effective, science-driven treatments to help your patients recover and thrive. Emcyte’s Bone Marrow Aspirate Concentrate (BMC) represents the future of regenerative medicine—harnessing the body’s own biological power to promote natural tissue repair and regeneration.
PureBMC® takes this innovation even further. Processed within a single, highly efficient concentrating device, PureBMC® delivers supraphysiologic levels of regenerative progenitor stem cells—including hematopoietic stem cells, mesenchymal stem cells, and total nucleated cells.
Through Emcyte’s streamlined system, complexity is removed while performance is amplified. The new ASPIRE™ Bone Marrow Harvesting System now enables superior cell procurement and quiescent cell collection, setting an unmatched standard for consistency and potency.
PureBMC® leads the field in point-of-care bone marrow concentrate performance—combining simplicity, precision, and the highest biologic yield to help clinicians deliver optimal regenerative outcomes.
PureBMC® + ASPIRE™: Redefining what’s possible in bone marrow–based regeneration.
- BC30-Pure – PureBMC®
- Concentrating System 30mL
- BC60-Pure – PureBMC®
- Concentrating System 60mL
- BC120-Pure – PureBMC®
- Concentrating System 120mL
Common Questions About Bone Marrow Aspirate Concentrate
What Is Bone Marrow Concentrate (BMC)?
Using advanced processing systems like Emcyte’s PureBMC®, clinicians can concentrate these regenerative components at the point of care, producing a biologically potent solution optimized for orthopedic, sports medicine, and wound healing applications.
BMC therapy harnesses the body’s inherent ability to repair itself—stimulating new tissue formation, reducing inflammation, and accelerating recovery.
Bone Marrow Concentrate: Precision in preparation, power in regeneration.
Platelet Concentration and Clinical Efficacy
Scientific research has demonstrated that optimal bone and soft tissue healing occurs when platelet-rich plasma (PRP) contains at least 1,000,000 platelets per microliter, equivalent to a concentration of approximately 1 billion platelets per milliliter.
Accordingly, for a 10 mL treatment sample of concentrated PRP (C‑PRP) to achieve clinical effectiveness, it should contain a minimum of 10 billion functional platelets. Many commercially available systems fail to reach this concentration threshold, limiting their therapeutic efficacy.
Why Choose Emcyte® Bone Marrow Concentrate?
What sets Emcyte® apart is a steadfast focus on quality, innovation, and patient outcomes. Our technologies empower clinicians to achieve optimal results through precise, reproducible biologic preparations.
Supported by a dedicated team of experts, Emcyte® partners closely with medical professionals to develop personalized treatment strategies—ensuring each patient receives the highest standard of regenerative care.
Emcyte®: Precision-engineered science. Proven clinical performance. Superior patient outcomes.
If you’re a physician seeking a safe, effective, and clinically advanced regenerative solution, look no further than Emcyte® Bone Marrow Concentrate (BMC). Designed with precision and backed by extensive clinical validation, Emcyte® BMC helps you deliver exceptional outcomes through the body’s own regenerative potential.
Contact us today to learn how Emcyte® BMC can help your patients achieve lasting recovery, restored mobility, and overall wellness—while enhancing the regenerative capabilities of your practice.